Navigating Quality Assessment Hurdles in Clinical Laboratory Services: A Comprehensive Review in Resource-Limited Settings

被引:2
作者
Cherie, Negesse [1 ]
Deress, Teshiwal [1 ]
Berta, Dereje Mengesha [2 ]
Chane, Elias [3 ]
Teketelew, Bisrat Birke [2 ]
Adane, Kasaw [1 ]
Nigus, Mesele [1 ]
机构
[1] Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Qual Assurance & Lab Management, Gondar, Ethiopia
[2] Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Hematol & Immunohematol, Gondar, Ethiopia
[3] Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Clin Chem, Gondar, Ethiopia
关键词
external quality assessment; proficiency testing; challenge; resource-limited countries; ASSESSMENT SCHEMES; EQA; HARMONIZATION; STANDARDIZATION; CHALLENGES; ASSURANCE; COMMUTABILITY; MEDICINE; PROGRAMS; HEALTH;
D O I
10.2147/RMHP.S453020
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
External quality assessment is the process of evaluating the performance of a laboratory and the competence of professionals. Participation in EQA and standardizing the quality of laboratory services are a mandatory requirements for accreditation. This review is aimed at identifying and discussing challenges that hinder the effective implementation of an EQA program in countries with resource limited setting. To obtain abundant information, articles were identified by searching the literature published in English using the National Library of Medicine, PubMed, Science Direct and AMC digital library databases. The articles identified in the references were manually searched and included. After the article was identified, it was imported to Endnote version 8.1 and exported to Microsoft Word for citation. Based on this review, the major identified challenges that hinder the implementation of an EQA program include the high cost of control materials, malfunction and lack of maintenance for equipment failure and breakdown, a knowledge gap among laboratory professionals, noncommutability of control samples, and difficulty in assigning target values. In addition, failing to participate in EQA and failing to take corrective action are the major challenges identified. As a result, applying to an EQA program in resource-limited counties was highly challenging. To attain high performance in the laboratory and to provide quality laboratory service for patient care, the EQA supplier and the user laboratory must pay attention to these issues and take appropriate corrective actions for ongoing quality improvement and accreditation.
引用
收藏
页码:497 / 504
页数:8
相关论文
共 68 条
  • [1] Automated and Manual Quantification of Tumour Cellularity in Digital Slides for Tumour Burden Assessment
    Akbar, Shazia
    Peikari, Mohammad
    Salama, Sherine
    Panah, Azadeh Yazdan
    Nofech-Mozes, Sharon
    Martel, Anne L.
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [2] [Anonymous], 2007, Antigenic formulae of the Salmonella serovars
  • [3] [Anonymous], 2016, QMS24 C
  • [4] [Anonymous], 2016, WHO manual for organizing a national external quality assessment programme for health laboratories and other testing sites
  • [5] [Anonymous], 1996, Guide I. Annex A: Proficiency Testing by Interlaboratory Comparisons-Part 1: Development and Operation of Proficiency Testing Schemes
  • [6] Interpreting EQA-Understanding Why Commutability of Materials Matters
    Badrick, Tony
    Miller, W. Greg
    Panteghini, Mauro
    Delatour, Vincent
    Berghall, Heidi
    MacKenzie, Finlay
    Jones, Graham
    [J]. CLINICAL CHEMISTRY, 2022, 68 (04) : 494 - 500
  • [7] Baldeshwiler A.M., 2003, Qual. Assur. J, V7, P157, DOI [10.1002/QAJ.228, DOI 10.1002/QAJ.228, 10.1002/qaj.228]
  • [8] Banoo S, 2006, NAT REV MICROBIOL, pS21, DOI [10.1038/nrmicro1523, 10.1038/nrmico1523]
  • [9] Belete R, 2021, Biomed J Sci Tech Res, V34, P26957, DOI [10.26717/BJSTR.2021.34.005584, DOI 10.26717/BJSTR.2021.34.005584]
  • [10] Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology
    Bera, Kaustav
    Schalper, Kurt A.
    Rimm, David L.
    Velcheti, Vamsidhar
    Madabhushi, Anant
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (11) : 703 - 715